top of page
Search

Med Spa Industry Trends for 2027: Which Numbers to Trust

Writer: Michael Madrinkian
Michael Madrinkian
4 days ago
8 min read

Updated: 1 day ago

The med spa industry trends that hold up for 2027 are slow growth at existing locations, fewer new patients, steady neurotoxin demand, and falling filler and weight loss spending. Published market sizes differ by more than two times. The Executive Advisory Retainer helps owners plan from numbers that fit.


By Michael Madrinkian, MBA, PhD, Founder and Principal, Luminary Strategic



THE SHORT ANSWER


  • Forecasts and measurements disagree. Research firms forecast 10% to 16% a year. Measured spending in the largest categories rose 3% to 6% in early 2026. Existing locations on one major software platform grew 2% in 2025.

  • The US market is probably about $15 billion to $20 billion. The two lowest published US figures would imply that the average med spa earns about half of what the industry's own association reports.

  • New locations are taking the growth. New patients fell from 55% of patients in 2021 to 41% in the year ending March 2026.

  • Neurotoxin is the base of the business. It grew about 4% in the first quarter of 2026 while fillers fell 5% and weight loss fell 22%.

  • Market size figures say little about your practice. Your same-location growth and your new-patient share say much more.


WHY THE MARKET SIZE FIGURES DISAGREE


Five research firms publish a global med spa figure for about the same year, ranging from $21.6 billion to $28.56 billion. Their forecasts spread much further. For 2034, IMARC projects $51.6 billion and Fortune Business Insights projects $108.9 billion, a gap of 2.1 times. We read the public summary pages only, since the full reports are sold, so the explanations below rest on what those summaries disclose.


They measure different places


Most headline numbers are global. A single-location owner in Texas has no use for a figure that includes Europe and Asia. Grand View Research's own US number is $9.1 billion for 2025, against $24.2 billion globally.


They count different businesses


Grand View's scope includes single-owner spas, group-owned spas, free-standing spas, and spas attached to medical practices. Precedence Research describes the market as cosmetic procedures including fillers and Botox. The American Med Spa Association (AmSpa) describes a "medical aesthetics" industry above $17 billion. Guidepoint Qsight measures patient spending at cash-pay med spas and aesthetic physician practices together. Each is a reasonable definition, and each produces a different total.


A simple check exposes the low figures


Divide a US market figure by the number of med spas and you get an implied average per location. AmSpa counted 10,488 med spas at the end of 2023, according to IMARC's citation. AmSpa's chief executive said in June 2024 that there were more than 11,000.


Using the 10,488 figure, Precedence's $7.43 billion implies about $708,000 per location, and Grand View's $9.1 billion implies about $868,000. AmSpa's reported average is about $1.4 million. Both cannot be right. Multiply the other way, and 10,488 locations at $1.4 million comes to about $14.7 billion, which sits much closer to AmSpa's $17 billion and to the consulting firm L.E.K.'s estimate of $12 billion to $13 billion for 2022 growing to $20 billion to $21 billion by 2027.


Qsight points in the same direction. It reports that US patients spent an estimated $6.4 billion on neurotoxin in 2024, 31% of non-surgical aesthetic spending. That implies about $20.6 billion in total, including physician practices. Separate 2025 trade coverage of Qsight data gave $17.5 billion for 2024, so even one source's number can move with scope or revision.


Taken together, a range of about $15 billion to $20 billion is our reading of what US med spa revenue looks like today. It is an estimate from public figures. No source publishes it.


Counts drift as well


Fortune Business Insights says more than 8,900 facilities operated in the US during 2025. A 2024 Meridian deck says 8,800 or more. AmSpa was already above 10,000 for the end of 2023. A figure repeated from an older edition can look current for years. AmSpa's own average also moves oddly, which is owning a medical spa profitable explains.


Who pays for each number


Research firms sell reports to investors and suppliers. A large growth figure suits that audience. AmSpa's figures come from an online survey of owners, and AmSpa sells memberships and the report itself. Zenoti measures its own customers and sells software. Qsight sells transaction data. None of this makes a number false. It tells you which way to check.


WHICH NUMBER FITS YOUR QUESTION



Four questions sort any statistic in a few minutes. Who measured it? What is inside the total? What year does it describe? Who is paying for it to be published? A number that survives all four is worth repeating. Most forecasts fail on the second and the fourth.


MED SPA INDUSTRY TRENDS THE MEASURED DATA SUPPORTS


The med spa industry trends below rest on measured spending or transactions, with the limits of each source stated.


Growth is coming from new doors


Zenoti's 2026 med spa report, covering calendar 2025 on its platform, shows total revenue up 8%, driven mainly by new locations, with same-location growth of 2%. New guest visits fell 11% and existing guest visits fell 2%. Its sample is its own customers, and it calls the figures directional. Even so, the pattern matters more than the precise values: the market can keep growing while a typical existing location barely moves.


New patients are harder to find


Qsight reports new patients as 41% of total patients for the twelve months ending March 2026, down from 55% in 2021. Average retention moved only from 51% to 53%. Owners who built their budgets on new-patient growth should rebuild them around keeping the patients they have. The med spa KPIs post shows how to measure both.


Neurotoxin holds, and fillers soften


Qsight's first-quarter 2026 spending shows neurotoxins at $1.7 billion, up 4%; energy-based devices at $1.0 billion, up 4%; other skin rejuvenation at $400 million, up 6%; and dermal fillers at $840 million, down 5%. In the American Society of Plastic Surgeons' 2025 report, neuromodulators made up half of minimally invasive treatments and hyaluronic fillers made up 30%. That report draws on member surgeons, so read it as a signal of direction for a different setting.


Weight loss spending is falling, and it has not fed the rest of the practice


Qsight shows weight loss spending at $490 million in the first quarter of 2026, down 22%. GLP-1 drugs make up about 6% of non-surgical spending. About 60% of patients who began a GLP-1 at an aesthetic practice were new to that practice. Fewer than 20% of patients who started that way have returned for a non-weight-loss purchase. Owners counting on weight loss patients to become injectable patients should check that assumption against their own records.


A visit with more than one service is worth much more


Qsight reports average spending of $478 on neurotoxin-only visits and $1,265 when the visit includes other items. Part of that gap reflects which patients buy more, so a practice should not expect the full difference from a cross-selling script. It does show where to look.


Memberships and loyalty are getting attention


Zenoti reports med spa membership sales up 13%. Qsight lists loyalty programs among the trends to watch. Growth in sales says little about whether a program earns money. Med spa membership ideas gives the math.


Younger patients are arriving, and they cost more to keep


Qsight puts Gen Z above 10% of aesthetic patients. It also reports year-over-year retention of 45% against 54% for older patients, and average spend per visit of $384 against $524.


Rules are changing state by state


Texas added statutory requirements for elective IV therapy effective September 1, 2025, and other states are active. National data will not tell you which rule reaches your service line. Texas med spa regulations summarizes the Texas framework. Your attorney decides how it applies. How Luminary approaches med spa compliance.


The market is still mostly single locations


Meridian's 2024 overview, citing AmSpa among its sources, reports that 81% of med spas are single locations. Consolidation gets the headlines, while most owners still compete one location at a time.


WHAT THIS MEANS FOR A SINGLE-LOCATION OWNER


  1. Calculate your same-location growth. Compare this year's revenue with last year's, excluding any new provider or service you added. That is your real trend.

  2. Budget from your own trend. A 15% market forecast is no reason to sign a lease or hire ahead of demand.

  3. Measure your new-patient share and your retention. If new patients are falling at your practice too, marketing alone will not fix it. Retention may be the cheaper place to work.

  4. Test what your weight loss line actually feeds. Pull the share of those patients who bought anything else within twelve months.

  5. Watch local supply. National data cannot tell you whether your market is crowded. AmSpa's own report states that it does not drill down to individual states or cities. Count what opened near you in the past two years.


Luminary takes no compensation from device makers, distributors, lenders, or software vendors, so it has no market story to sell. How Luminary stays independent.


WHAT ONGOING ADVICE COSTS


The Executive Advisory Retainer provides twelve months of counsel with a monthly session and a written quarterly review, from $5,000 per month, after a completed Diagnostic or Engagement. Owners who want to start by seeing where their own numbers stand use the Practice Diagnostic, three weeks, from $5,000. Luminary is an independent firm of medical spa consultants.


FREQUENTLY ASKED QUESTIONS


How big is the US med spa industry?


Our reading of public figures is about $15 billion to $20 billion. AmSpa describes a medical aesthetics industry above $17 billion. Lower figures from research firms imply an average location far below what AmSpa reports.


How many med spas are there in the United States?


AmSpa's count was 10,488 at the end of 2023, as cited by IMARC. Its chief executive said more than 11,000 in June 2024. Figures near 8,900 appear to repeat an older count.


Is the med spa industry still growing?


Yes, more slowly than most forecasts suggest. Measured spending in the largest non-surgical categories grew low to mid single digits in early 2026. Much of the growth in location revenue comes from new locations.


Is the med spa market saturated?


National data cannot answer that. It depends on your local competitors, your service mix, and your retention. Falling new-patient share suggests that competition for new patients is rising across the industry.


Why do med spa market reports show such different numbers?


They cover different geographies, count different kinds of businesses, and project from different starting points. Most also sell to investors. Only their summaries are public, so their methods are hard to check.


REQUEST A SCOPING CALL


Luminary works with med spa and wellness practice owners in person across Dallas-Fort Worth and virtually nationwide. A scoping call is 30 minutes and confirms which engagement fits. Request a scoping call or call 469-894-8793.


SOURCES


Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
Luminary Logo

7200 W University Dr., Ste 200

McKinney, TX 75071​

469-894-8793​

  • Facebook
  • Twitter

Strategic advisory for med spa owners. In person across Dallas-Fort Worth, virtually nationwide.

© 2026 Luminary Strategic. All rights reserved.

Privacy

Terms & Conditions 

bottom of page